{"id":"W2744041560","doi":"10.1038/leu.2017.247","title":"Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network; University of Toronto; McMaster University","funders":"Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Imatinib; Medicine; Randomized controlled trial; Oncology; Internal medicine; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001481788,0.0005665492,0.001585956,0.0004848762,0.0002758309,0.0001298935,0.0005494209,0.0002737744,0.00007299647],"category_scores_gemma":[0.01629974,0.0004787495,0.0005296237,0.0002353423,0.0001162303,0.0001170965,0.0003540186,0.0004320994,0.000357854],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005884054,"about_ca_system_score_gemma":0.001452109,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000976035,"about_ca_topic_score_gemma":0.0001090968,"domain_scores_codex":[0.9954953,0.0004753982,0.00116709,0.001021647,0.0009576887,0.0008828834],"domain_scores_gemma":[0.9959071,0.0007904854,0.0004542744,0.001961197,0.000273409,0.0006135244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9886918,0.0005305111,0.0008107961,0.00005743127,0.0002299116,0.0009496617,0.001400864,0.0003415527,0.0005514435,0.00007715589,0.0007095031,0.005649343],"study_design_scores_gemma":[0.9683108,0.004534452,0.02091214,0.0004884984,0.0002903623,0.00002006199,0.0001954017,0.0006534702,0.003484981,0.00006739501,0.0005672913,0.0004751508],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984322,0.00003480931,0.00006625393,0.00324339,0.0005055827,0.006662149,0.00004351813,0.00009814368,0.00502419],"genre_scores_gemma":[0.9915544,0.000005901907,0.001995818,0.001590025,0.0002359968,0.0006622886,0.0001343166,0.00008832889,0.003732921],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02038103,"threshold_uncertainty_score":0.9997664,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0239290547485834,"score_gpt":0.2993948302622677,"score_spread":0.2754657755136843,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}